Brugada Syndrome Type 2 ECG Pattern
A Type 2 Brugada ECG pattern is NOT diagnostic of Brugada syndrome and requires further evaluation with sodium channel blocker challenge testing to unmask a diagnostic Type 1 pattern before any clinical decisions are made.
ECG Characteristics
The Type 2 Brugada pattern shows a "saddleback" morphology with 1:
- High takeoff ST-segment elevation ≥2 mm
- ST-segment remaining ≥1 mm above baseline
- Followed by a biphasic or positive T-wave in leads V1-V2
This contrasts with the diagnostic Type 1 pattern, which shows a "coved" ST-segment elevation ≥2 mm followed by a negative T-wave 1.
Clinical Significance and Risk
The Type 2 pattern alone carries minimal to no arrhythmic risk. Multiple lines of evidence support this:
In a Finnish population study of 3,021 healthy subjects followed for up to 19 years, those with Type 2 or 3 patterns had zero mortality or life-threatening ventricular arrhythmias, suggesting these patterns represent normal variants in asymptomatic individuals without family history 2
Only the Type 1 pattern is diagnostic of Brugada syndrome 1, 3
Asymptomatic patients with drug-induced (not spontaneous) Type 1 patterns have much better prognosis than those with spontaneous Type 1 patterns 4
Management Algorithm
Step 1: Assess Clinical Context
Evaluate for:
- Symptoms: History of syncope, cardiac arrest, or documented ventricular arrhythmias
- Family history: Brugada syndrome or sudden cardiac death in relatives
- Triggers: Fever, certain medications, electrolyte disturbances 1
Step 2: Risk-Based Approach
For ASYMPTOMATIC patients with Type 2 pattern and NO family history:
- Do NOT perform sodium channel blocker challenge 4
- Observation without treatment is appropriate 5
- The specificity of drug challenge in this population is questionable, and the test should not be performed 4
For patients with Type 2 pattern AND symptoms OR positive family history:
- Perform sodium channel blocker challenge (ajmaline, flecainide, or procainamide) to unmask potential Type 1 pattern 1, 6, 7
- Use high electrode positioning (second and third intercostal spaces) to improve detection 7
- Terminate test if ventricular arrhythmias, marked QRS widening, or Type 1 pattern develops 7
Step 3: Post-Challenge Management
If challenge reveals Type 1 pattern:
- Confirm diagnosis of Brugada syndrome 3
- Risk stratify based on symptoms:
- Cardiac arrest survivors or sustained VT: ICD implantation (Class I recommendation) 3, 7
- Syncope with spontaneous Type 1: ICD should be considered (Class IIa) 3
- Asymptomatic with spontaneous Type 1: Observation; electrophysiology study may be considered for further risk stratification (Class IIb) 7, 5
If challenge remains Type 2/3:
Critical Pitfalls to Avoid
Do not diagnose Brugada syndrome based on Type 2 pattern alone - this requires Type 1 pattern for diagnosis 1, 6
Do not perform drug challenge in asymptomatic patients with Type 2 pattern and no family history - the specificity is poor and risk is extremely low 4
Do not confuse Type 2 pattern with athletic heart changes - athletes may show similar ST elevations with upsloping morphology (ST/ST80 ratio <1) versus the downsloping pattern in true Brugada (ratio >1) 1
Avoid triggers: Counsel all patients with any Brugada pattern to avoid fever (treat aggressively with antipyretics), excessive alcohol, large meals, and specific medications (www.brugadadrugs.org) 3, 7
Genetic Testing
Genetic testing is NOT recommended for Type 2 patterns 6. Even in confirmed Brugada syndrome with Type 1 patterns, genetic testing identifies causative mutations in only 20-30% of cases (primarily SCN5A) and is primarily useful for family screening, not risk stratification 6, 7.